Antibody therapeutics production, clinical trials, and strategic issues : report no. 9039, November 2001 authors, Rathin C. Das and K. John Morrow, Jr. ; managing editor, Susan C. DiClemente

Text Registration

Antibody therapeutics production, clinical trials, and strategic issues : report no. 9039, November 2001 authors, Rathin C. Das and K. John Morrow, Jr. ; managing editor, Susan C. DiClemente

Status

Published

on 15 Jun 2007

Year of Creation

2001

Drug & Market Development Publications

Registration Number

TX0005821986

on 15 Jun 2007

The U.S. Copyright record (Registration Number: TX0005821986) dated 15 Jun 2007, pertains to an electronic file (eService) titled "Antibody therapeutics production, clinical trials, and strategic issues : report no. 9039, November 2001 authors, Rathin C. Das and K. John Morrow, Jr. ; managing editor, Susan C. DiClemente" created in 2001. The copyright holder is Drug & Market Development Publications, known for their creative contributions in text registration. For any inquiries concerning this copyrighted material, kindly reach out to Drug & Market Development Publications.

Drug & Market Development Publications

Application Details

Registration Number

TX0005821986

Registration Date

6/15/2007

Year of Creation

2001

Place of First Publication

Westborough, MA

Publisher Name

D&MD Reports

Agency Marc Code

DLC-CO

Record Status

New

Physical Description

1 v

Personal Authors

Rathin C Das

Jr K. John Morrow

Susan C DiClemente

Corporate Authors

Drug & Market Development Publications

Statements

Author Statement: co-authors: Rathin Das & K. John Morrow, Jr., authors of a work made for hire

Statements

Author Statement: co-authors: Rathin Das & K. John Morrow, Jr., authors of a work made for hire

Get your copyright registered todayThousands have copyrighted their assets.
What are you waiting for?

Show terms & conditions

Disclaimer: The information contained in this website is provided for informational purposes only, and should not be construed as legal advice. Although LegalForce RAPC Worldwide P.C., dba Trademarkia P.C., is a law firm (the “Firm”), your use of this website does not establish an attorney-client relationship with the Firm. Such a relationship can only be established after the Firm decides that it is willing and able to accept the engagement after a conflict check and after a written retainer agreement is agreed upon between you and the Firm. Your use of this website is also subject to our Terms of Use and Privacy Policy. ** The entry level subscription is a bundled price which requires a minimum of two billing cycles, or 6 months.